221 related articles for article (PubMed ID: 22685544)
1. BRCA1 regulates follistatin function in ovarian cancer and human ovarian surface epithelial cells.
Karve TM; Preet A; Sneed R; Salamanca C; Li X; Xu J; Kumar D; Rosen EM; Saha T
PLoS One; 2012; 7(6):e37697. PubMed ID: 22685544
[TBL] [Abstract][Full Text] [Related]
2. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
Huang M; Wang Q; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
[TBL] [Abstract][Full Text] [Related]
3. EZH2 participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1.
Li T; Cai J; Ding H; Xu L; Yang Q; Wang Z
Cancer Biol Ther; 2014 Mar; 15(3):271-8. PubMed ID: 24335192
[TBL] [Abstract][Full Text] [Related]
4. Proliferation of rat small hepatocytes requires follistatin expression.
Ooe H; Chen Q; Kon J; Sasaki K; Miyoshi H; Ichinohe N; Tanimizu N; Mitaka T
J Cell Physiol; 2012 Jun; 227(6):2363-70. PubMed ID: 21826650
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.
Wang Y; Wang Y; Wei L; Hong S; Zhao M; Zhang X; Zheng W
J Ovarian Res; 2017 Mar; 10(1):12. PubMed ID: 28270171
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profile analysis in response to α1,2-fucosyl transferase (FUT1) gene transfection in epithelial ovarian carcinoma cells.
Gao S; Zhu L; Feng H; Hu Z; Jin S; Song Z; Liu D; Liu J; Hao Y; Li X; Lin B
Tumour Biol; 2016 Sep; 37(9):12251-12262. PubMed ID: 27240592
[TBL] [Abstract][Full Text] [Related]
7. BRCA1 expression is epigenetically repressed in sporadic ovarian cancer cells by overexpression of C-terminal binding protein 2.
May T; Yang J; Shoni M; Liu S; He H; Gali R; Ng SK; Crum C; Berkowitz RS; Ng SW
Neoplasia; 2013 Jun; 15(6):600-8. PubMed ID: 23730208
[TBL] [Abstract][Full Text] [Related]
8. Activin is a potent growth suppressor of epithelial ovarian cancer cells.
Ramachandran A; Marshall ES; Love DR; Baguley BC; Shelling AN
Cancer Lett; 2009 Nov; 285(2):157-65. PubMed ID: 19493612
[TBL] [Abstract][Full Text] [Related]
9. BRCA1-mediated signaling pathways in ovarian carcinogenesis.
Karve TM; Li X; Saha T
Funct Integr Genomics; 2012 Mar; 12(1):63-79. PubMed ID: 21887486
[TBL] [Abstract][Full Text] [Related]
10. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
11. Lentivirus-Mediated Short Hairpin RNA for Follistatin Downregulation Suppresses Tumor Progression in Hypopharyngeal Carcinoma.
Ge L; Liu SF
Curr Med Sci; 2022 Aug; 42(4):832-840. PubMed ID: 35864413
[TBL] [Abstract][Full Text] [Related]
12. Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer.
Szabova L; Yin C; Bupp S; Guerin TM; Schlomer JJ; Householder DB; Baran ML; Yi M; Song Y; Sun W; McDunn JE; Martin PL; Van Dyke T; Difilippantonio S
Cancer Res; 2012 Aug; 72(16):4141-53. PubMed ID: 22617326
[TBL] [Abstract][Full Text] [Related]
13. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
[TBL] [Abstract][Full Text] [Related]
14. Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.
Chiyoda T; Hart PC; Eckert MA; McGregor SM; Lastra RR; Hamamoto R; Nakamura Y; Yamada SD; Olopade OI; Lengyel E; Romero IL
Cancer Prev Res (Phila); 2017 Apr; 10(4):255-266. PubMed ID: 28264838
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of microRNA-630 inhibits cell proliferation and invasion and enhances chemosensitivity in human ovarian carcinoma.
Zou YT; Gao JY; Wang HL; Wang Y; Wang H; Li PL
Genet Mol Res; 2015 Jul; 14(3):8766-77. PubMed ID: 26345808
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
Yan H; Wu W; Ge H; Li P; Wang Z
Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115
[TBL] [Abstract][Full Text] [Related]
18. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
19. Down-regulated aquaporin 5 inhibits proliferation and migration of human epithelial ovarian cancer 3AO cells.
Yan C; Zhu Y; Zhang X; Chen X; Zheng W; Yang J
J Ovarian Res; 2014 Aug; 7():78. PubMed ID: 25298246
[TBL] [Abstract][Full Text] [Related]
20. Expression and function of HOXA genes in normal and neoplastic ovarian epithelial cells.
Ota T; Klausen C; Salamanca MC; Woo HL; Leung PC; Auersperg N
Differentiation; 2009 Feb; 77(2):162-71. PubMed ID: 19281776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
